Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$1.39 -4.79%
Market Cap
$194.7M
Price Target
Refer to Report
Volume
9.6M
52wk Range
$0.1611 - $3.39
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.